TAVOCEPT

Serial Number 97510148
731

Registration Progress

Application Filed
Jul 19, 2022
Under Examination
Jul 9, 2024
Approved for Publication
May 14, 2024
Published for Opposition
May 14, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 2 Granted
Due: Jan 09, 2026 157 days

Trademark Image

TAVOCEPT

Basic Information

Serial Number
97510148
Filing Date
July 19, 2022
Published for Opposition
May 14, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
731
Status Date
Jul 9, 2025
Application
Pending
Classes
005

Rights Holder

Lantern Pharma Inc.

03
Address
1920 McKinney Avenue
Dallas, TX 75201

Ownership History

Lantern Pharma Inc.

Original Applicant
03
Dallas, TX

Lantern Pharma Inc.

Owner at Publication
03
Dallas, TX

Legal Representation

Attorney
Nigamnarayan Acharya

USPTO Deadlines

Next Deadline
157 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
January 09, 2026
Extension Available
Until July 09, 2025

Application History

38 events
Date Code Type Description Documents
Jul 10, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 9, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 9, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 9, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 27, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 27, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 7, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 7, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 7, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 7, 2025 PETG O PETITION TO REVIVE-GRANTED Loading...
Apr 7, 2025 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Apr 7, 2025 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
Apr 7, 2025 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Feb 10, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Feb 10, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jan 8, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 9, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 14, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 14, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 24, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 9, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 9, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 9, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 8, 2024 ALIE A ASSIGNED TO LIE Loading...
Nov 17, 2023 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Nov 17, 2023 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Nov 17, 2023 PETG O PETITION TO REVIVE-GRANTED Loading...
Nov 17, 2023 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Nov 17, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 21, 2023 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Sep 21, 2023 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Sep 21, 2023 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Jun 7, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 7, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 7, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 3, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 9, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 22, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, medications used in chemotherapeutic regimens for the treatment of cancer; pharmaceutical preparations for the treatment of cancer

Classification

International Classes
005